UA87128C2 - ИММУНОГЛОБУЛИН АНТИ-EрCAM И СПОСОБ ЕГО ВВЕДЕНИЯ ДЛЯ ЛЕЧЕНИЯ ОНКОЛОГИЧЕСКИХ ЗАБОЛЕВАНИЙ - Google Patents

ИММУНОГЛОБУЛИН АНТИ-EрCAM И СПОСОБ ЕГО ВВЕДЕНИЯ ДЛЯ ЛЕЧЕНИЯ ОНКОЛОГИЧЕСКИХ ЗАБОЛЕВАНИЙ

Info

Publication number
UA87128C2
UA87128C2 UAA200608985A UAA200608985A UA87128C2 UA 87128 C2 UA87128 C2 UA 87128C2 UA A200608985 A UAA200608985 A UA A200608985A UA A200608985 A UAA200608985 A UA A200608985A UA 87128 C2 UA87128 C2 UA 87128C2
Authority
UA
Ukraine
Prior art keywords
administration
treatment
immunoglobulin
eрcam
oncological diseases
Prior art date
Application number
UAA200608985A
Other languages
English (en)
Russian (ru)
Ukrainian (uk)
Inventor
Мальте Петерс
Матиас Лочер
Надя Пранг
Корнелия Квадт
Original Assignee
Микромет Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Микромет Аг filed Critical Микромет Аг
Publication of UA87128C2 publication Critical patent/UA87128C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
UAA200608985A 2004-02-13 2005-02-09 ИММУНОГЛОБУЛИН АНТИ-EрCAM И СПОСОБ ЕГО ВВЕДЕНИЯ ДЛЯ ЛЕЧЕНИЯ ОНКОЛОГИЧЕСКИХ ЗАБОЛЕВАНИЙ UA87128C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/778,915 US20050180979A1 (en) 2004-02-13 2004-02-13 Anti-EpCAM immunoglobulins

Publications (1)

Publication Number Publication Date
UA87128C2 true UA87128C2 (ru) 2009-06-25

Family

ID=34838270

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200608985A UA87128C2 (ru) 2004-02-13 2005-02-09 ИММУНОГЛОБУЛИН АНТИ-EрCAM И СПОСОБ ЕГО ВВЕДЕНИЯ ДЛЯ ЛЕЧЕНИЯ ОНКОЛОГИЧЕСКИХ ЗАБОЛЕВАНИЙ

Country Status (23)

Country Link
US (3) US20050180979A1 (enExample)
EP (2) EP2107071A3 (enExample)
JP (1) JP5220315B2 (enExample)
KR (1) KR101236224B1 (enExample)
CN (1) CN1976951B (enExample)
AT (1) ATE437186T1 (enExample)
AU (1) AU2005215874B2 (enExample)
BR (1) BRPI0507660A (enExample)
CA (1) CA2555694C (enExample)
DE (1) DE602005015544D1 (enExample)
DK (1) DK1713830T3 (enExample)
EA (1) EA011951B1 (enExample)
ES (1) ES2328159T3 (enExample)
IL (1) IL177069A (enExample)
MX (1) MXPA06008942A (enExample)
NO (1) NO339364B1 (enExample)
NZ (1) NZ549125A (enExample)
PL (1) PL1713830T3 (enExample)
PT (1) PT1713830E (enExample)
SI (1) SI1713830T1 (enExample)
UA (1) UA87128C2 (enExample)
WO (1) WO2005080428A2 (enExample)
ZA (1) ZA200606083B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5686493B2 (ja) 2003-01-24 2015-03-18 ユニバーシティ・オブ・ユタＵｎｉｖｅｒｓｉｔｙ Ｏｆ Ｕｔａｈ テロメアの長さを決定することによって死亡の危険性を予測する方法
EP2004695A2 (en) 2005-07-08 2008-12-24 Xencor, Inc. Optimized anti-ep-cam antibodies
US7976842B2 (en) * 2006-02-09 2011-07-12 Micromet Ag Treatment of metastatic breast cancer
EP2041181B1 (en) * 2006-06-08 2011-05-18 Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Specific protease inhibitors and their use in cancer therapy
EP1865001A1 (en) * 2006-06-08 2007-12-12 Gsf-Forschungszentrum Für Umwelt Und Gesundheit, Gmbh Specific protease inhibitors and their use in cancer therapy
ES2367675T3 (es) * 2007-04-04 2011-11-07 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Anticuerpo anti-epcam y usos del mismo.
JP5840950B2 (ja) 2008-12-22 2016-01-06 ユニバーシティ・オブ・ユタ・リサーチ・ファウンデイション 単色マルチプレックス定量ｐｃｒ
JP6048660B2 (ja) * 2009-09-21 2016-12-21 ランジュ ラルハン 甲状腺癌を診断および処置するための方法および組成物
CN104168916B (zh) * 2012-03-02 2017-07-04 中央研究院 抗上皮细胞黏着分子(EpCAM)抗体及其使用方法
CN103387988B (zh) * 2012-09-24 2016-01-06 厦门大学 上皮细胞粘附分子的核酸适体EpCAM Ccut及其制备方法
CN105283559A (zh) 2013-05-22 2016-01-27 端粒诊断公司 短端粒丰度的量度
CN103275226B (zh) * 2013-06-09 2017-08-29 中国科学技术大学 特异性抗人上皮细胞粘附分子（EpCAM）的单克隆抗体的制备、鉴定及应用
AU2015204766B2 (en) * 2014-01-08 2020-08-13 The Board Of Trustees Of The Leland Stanford Junior University Targeted therapy for small cell lung cancer
AU2015372584A1 (en) 2014-12-30 2017-06-29 Telomere Diagnostics, Inc. Multiplex quantitative PCR
EP3903818A1 (en) * 2015-11-19 2021-11-03 Revitope Limited Functional antibody fragment complementation for a two-components system for redirected killing of unwanted cells
AU2017301826A1 (en) 2016-07-26 2019-03-14 Tessa Therapeutics Ltd. Chimeric antigen receptor
WO2020018964A1 (en) 2018-07-20 2020-01-23 Fred Hutchinson Cancer Research Center Compositions and methods for controlled expression of antigen-specific receptors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5853697A (en) * 1995-10-25 1998-12-29 The United States Of America, As Represented By The Department Of Health & Human Services Methods of treating established colitis using antibodies against IL-12
TR199902553T2 (xx) * 1997-04-14 2000-03-21 Micromet Gesellschaft F�R Biomedizinische Forschung Mbh �nsan v�cuduna kar�� antijen resept�rlerinin �retimi i�in yeni metod ve kullan�mlar�.
US6855544B1 (en) * 1999-04-15 2005-02-15 Crucell Holland B.V. Recombinant protein production in a human cell
US7605238B2 (en) * 1999-08-24 2009-10-20 Medarex, Inc. Human CTLA-4 antibodies and their uses
KR100900166B1 (ko) * 2001-05-03 2009-06-02 메르크 파텐트 게엠베하 재조합 종양 특이적 항체 및 이들의 용도
US20030175268A1 (en) * 2002-01-11 2003-09-18 Saint-Remy Jean-Marie R. Method and pharmaceutical composition for preventing and/or treating systemic inflammatory response syndrome
EP1575491A4 (en) * 2002-05-20 2006-09-27 Abgenix Inc TREATMENT OF RENAL CARCINOMA USING ANTIBODIES AGAINST THE EPIDERMAL GROWTH FACTOR RECEPTOR

Also Published As

Publication number Publication date
AU2005215874B2 (en) 2011-01-27
PT1713830E (pt) 2009-10-19
AU2005215874A1 (en) 2005-09-01
IL177069A (en) 2010-11-30
KR101236224B1 (ko) 2013-02-22
DE602005015544D1 (de) 2009-09-03
ES2328159T3 (es) 2009-11-10
HK1096103A1 (en) 2007-05-25
US20050180979A1 (en) 2005-08-18
EP2107071A3 (en) 2009-12-30
CA2555694C (en) 2013-04-16
EA200601386A1 (ru) 2007-06-29
WO2005080428A2 (en) 2005-09-01
EP1713830B1 (en) 2009-07-22
PL1713830T3 (pl) 2010-01-29
WO2005080428A3 (en) 2005-11-10
SI1713830T1 (sl) 2009-10-31
EP2107071A2 (en) 2009-10-07
CN1976951A (zh) 2007-06-06
JP2008500277A (ja) 2008-01-10
CA2555694A1 (en) 2005-09-01
EP1713830A2 (en) 2006-10-25
IL177069A0 (en) 2006-12-10
ATE437186T1 (de) 2009-08-15
BRPI0507660A (pt) 2007-07-17
EA011951B1 (ru) 2009-06-30
US20120294873A1 (en) 2012-11-22
DK1713830T3 (da) 2009-10-12
ZA200606083B (en) 2007-10-31
US20070274982A1 (en) 2007-11-29
MXPA06008942A (es) 2007-01-26
KR20070009988A (ko) 2007-01-19
NZ549125A (en) 2008-09-26
NO339364B1 (no) 2016-12-05
NO20064136L (no) 2006-11-07
CN1976951B (zh) 2012-03-14
JP5220315B2 (ja) 2013-06-26

Similar Documents

Publication Publication Date Title
NZ582150A (en) Antibodies to human programmed death receptor pd-1
NZ597676A (en) Crystalline anti-hTNFalpha antibodies
IS8432A (is) Mótefni sem bindast viðtaka hvítfrumuboða-4
NZ717847A (en) Human antigen binding proteins that bind beta-klotho, fgf receptors and complexes thereof
NZ599193A (en) Siglec 15 antibodies in treating bone loss-related disease
NZ619953A (en) Human cytomegalovirus neutralizing antibodies and use thereof
GEAP201811194A (en) Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors
MX349481B (es) Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
NZ595792A (en) Antibodies specific to cadherin-17
IL228068A0 (en) Antibodies specific to fcyriib and methods of using them
NZ598063A (en) Gram-positive bacteria specific binding compounds
NZ600768A (en) Human antibodies to human angiopoietin-like protein 4
ZA200609407B (en) Monoclonal antibodies to hepatocyte growth factor
PL1692516T3 (pl) Sposób terapii
IN2014CN00614A (enExample)
IL162384A0 (en) Composition inhibiting matrix-metallproteinases for the treatment of neoplastic diseases
EA200601386A1 (ru) ИММУНОГЛОБУЛИНЫ ПРОТИВ АНТИГЕНА EpCAM
SI1684770T1 (sl) Oligo-beta-(1,3)-glukan in monoklonska protitelesa proti raku
AU2003263712A1 (en) Peptide-based passive immunization therapy for treatment of atherosclerosis
DE602006019977D1 (de) Therapie mit anti-cd4-antikörpern und bestrahlung
UA89800C2 (en) Acylated nonadepsipeptides used as lysobactin derivatives
SG156658A1 (en) Treatment of diseases
IL174134A0 (en) Use of a protein in the preparation of a medicament for treatment of fibrotic diseases
NZ603751A (en) Composition for treating disease
HK1107357A (zh) 用作溶杆菌素衍生物的醯化九酯肽类